A cohort of 8,127 women in the UK who started GLP-1 receptor agonist therapy through a digital platform lost weight at six months at rates comparable to randomized clinical trials, suggesting remote care can deliver real-world results.
Digital-First GLP-1 Therapy Matches Trial Weight Loss in UK Women
A cohort of 8,127 women in the UK who started GLP-1 receptor agonist therapy through a digital platform lost weight at six months at rates comparable to randomized clinical trials, suggesting remote care can deliver real-world results.
Shixart1985 · CC BY 2.0 · rights
This item was produced with AI assistance under the editorial responsibility of Haydamax OÜ.
Monitoring item. The full text is not distributed. Extract and source below.